Search research articles
Contact Us
Filters
Showing results (181-190 of 239) with videos related to
Page
of 24
Sort By:
Gynecologic Oncology
|
January 31, 2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
Thomas J Herzog, Bradley J Monk, Peter G Rose, et al.
Frontiers in Oncology
|
July 8, 2014
Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines
Brittany Anne Davidson, Jennifer M Rubatt, David L Corcoran, et al.
Gynecologic Oncology
|
May 5, 2012
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers
Amanda Nickles Fader, Leigh G Seamon, Pedro F Escobar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer
Robert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
Gynecologic Oncology
|
February 23, 2025
Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression
Amma Asare, Rebecca Ann Previs, Daniel Spinosa, et al.
Gynecologic Oncology Reports
|
June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers
Stéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Gynecologic Oncology Reports
|
August 9, 2021
Placental uterine artery embolization followed by delayed hysterectomy for placenta percreta: A case series
Luke A Gatta, Paula S Lee, Jennifer B Gilner, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2012
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
Gordana Vlahovic, Kellen L Meadows, Hope E Uronis, et al.
American Journal of Perinatology
|
August 16, 2022
Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy
Luke A Gatta, Jeremy M Weber, Jennifer B Gilner, et al.
Gynecologic Oncology
|
August 29, 2009
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
Amanda Nickles Fader, David Starks, Paola A Gehrig, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 239) with videos related to
Sort By:
Page
of 24
Gynecologic Oncology
|
January 31, 2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
Thomas J Herzog, Bradley J Monk, Peter G Rose, et al.
Frontiers in Oncology
|
July 8, 2014
Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines
Brittany Anne Davidson, Jennifer M Rubatt, David L Corcoran, et al.
Gynecologic Oncology
|
May 5, 2012
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers
Amanda Nickles Fader, Leigh G Seamon, Pedro F Escobar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer
Robert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
Gynecologic Oncology
|
February 23, 2025
Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression
Amma Asare, Rebecca Ann Previs, Daniel Spinosa, et al.
Gynecologic Oncology Reports
|
June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers
Stéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Gynecologic Oncology Reports
|
August 9, 2021
Placental uterine artery embolization followed by delayed hysterectomy for placenta percreta: A case series
Luke A Gatta, Paula S Lee, Jennifer B Gilner, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2012
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
Gordana Vlahovic, Kellen L Meadows, Hope E Uronis, et al.
American Journal of Perinatology
|
August 16, 2022
Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy
Luke A Gatta, Jeremy M Weber, Jennifer B Gilner, et al.
Gynecologic Oncology
|
August 29, 2009
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
Amanda Nickles Fader, David Starks, Paola A Gehrig, et al.
Page
of 24